Effect of exercise timing on postprandial lipemia in hypertriglyceridemic men

Can J Appl Physiol. 2004 Oct;29(5):590-603. doi: 10.1139/h04-038.

Abstract

We investigated the effect of exercise timing on attenuation of postprandial hyper-triglyceridemia (PHTG) in individuals with hypertriglyceridemia (HTG). Subjects were 10 males (TG = 290.1 +/- 28.5 mg/dl). Each subject performed a control trial (Ctr), 12-hr premeal exercise trial (12-hr Pre), and 24-hr premeal exercise trial (24-hr Pre). In each trial, subjects had a fat-rich meal. In the exercise trials they jogged on a treadmill at 60% of their VO2max for 1 hr at a designated time. Blood samples were taken at 0 (immediately before the fat meal), and at 2, 4, 6, 8, and 24 hrs after the meal. The results indicated that plasma TG concentrations in 12-hr Pre were lower than in Ctr and 24-hr Pre (p < 0.03). The area score under the TG concentration curve (TG AUC score) in 12-hr Pre was 37% and 33% lower than in 24-hr Pre and Ctr (p < 0.02), respectively. Insulin concentrations in 12-hr Pre were lower than Ctr and 24-hr Pre (p < 0.001). The plasma nonesterified fatty acid (NEFA) concentration was higher in 12-hr Pre than in both 24-hr Pre and Ctr (p < 0.003). There were no trial differences in both HDLtot-Ch and HDL2-Ch. These results suggest that exercising 12 hrs prior to a fat-meal intake significantly reduces PHTG response whereas exercising 24 hrs prior to the meal does not attenuate PHTG in hypertriglyceridemic men. The effect of an acute exercise bout on PHTG lowering may be short-lived and diminished by 24 hrs.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cholesterol, HDL / blood
  • Exercise / physiology*
  • Fatty Acids, Nonesterified / blood
  • Humans
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / metabolism
  • Hypertriglyceridemia / physiopathology*
  • Insulin / blood
  • Lipoprotein Lipase / blood
  • Male
  • Postprandial Period
  • Time Factors
  • Triglycerides / blood
  • Triglycerides / pharmacokinetics*

Substances

  • Cholesterol, HDL
  • Fatty Acids, Nonesterified
  • Insulin
  • Triglycerides
  • Lipoprotein Lipase